NCT01941199View on ClinicalTrials.gov

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

DA-1229

DRUG

metformin

DRUG

DA-1229 + metformin

Trial Locations (1)

110-744

Clinical Trial Center, Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Dong-A Pharmaceutical Co., Ltd.

INDUSTRY

NCT01941199 - Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects | Biotech Hunter | Biotech Hunter